drugset / Trial / NCT05772871

The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

NCT05772871

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This non-inferiority study aims to compare the efficacy of Prednisone combined with Huaiqihuang Granule against Prednisone combined with Levamisole in the treatment of primary nephrotic syndrome (PNS) in children.

Timeline

Start
2023-04-26
Primary completion
2025-09-15
Completion
2025-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Huaiqihuang Granule Unknown 5 g Oral
Subject Huaiqihuang Granule Unknown 10 g Oral
Subject Huaiqihuang Granule Unknown 15 g Oral
Subject Huaiqihuang Granule Unknown 20 g Oral
Subject Huaiqihuang Granule Unknown 30 g Oral
Comparator Levamisole Small molecule 1.25 mg/kg
Subject Prednisone Other / unclassified 2 mg/kg Oral

Indications